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The fraction of polyclonal caldesmon antibodies cross-reacting with rabbit skeletal troponin T are shown to compete with smooth muscle tropo- 
myosin for caldesmon and troponin T, as revealed by ELISA method. The epitope recognized by these antibodies was also found in M, 77 kDa 
non-muscle caldesmon. These results provide functional confirmation for the suggestion that the regions of amino acid sequence homology in caldes- 
mon isoforms and troponin T belong to the tropomyosin binding sites. 
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1. INTRODUCTION 
Caldesmon and troponin are structurally different 
but functionally similar proteins involved in the thin 
filament-based system for the regulation of contraction 
in smooth and striated muscles, respectively [l-3]. It 
has been recently shown that caldesmon and the 
troponin T subunit of skeletal troponin share common 
antigenic determinants and the sites with high degree of 
primary structure homology [4-61. These amino acid se- 
quences were suggested to belong to tropomyosin bind- 
ing site. In the present work we confirm this suggestion 
by demonstrating that tropomyosin competes with the 
troponin T-specific pool of caldesmon antibodies for 
common sites on skeletal troponin T and smooth mus- 
cle caldesmon. We have demonstrated also that similar 
epitopes are present in non-muscle caldesmon. 
demonstrated no cross-reaction with immobilized tropomyosin. SDS- 
PAGE was performed according to the method of Laemmli [12] and 
electroblotting procedure was accomplished as described by Towbin 
et al. [13]. 
Competitive binding was assessed by ELISA method. Smooth mus- 
cle caldesmon (0.5 pg/ml) and skeletal muscle troponin T (4.0~g/ml) 
were immobilized in 96-well microtitration plates by incubation for 3 
h at 37°C in 0.01 M carbonate-bicarbonate buffer (pH 9.6) in a 
humidified atmosphere. Unbound material was washed out with 
phosphate buffered saline (PBS) containing 0.05% Tween-20. 
Tropomyosin (lOpg/ml) in PBWTween was incubated for 30 min at 
37°C followed by the addition of TNT-S AB in PBS/Tween. Alter- 
natively, the mixture of 8 pg/ml TNT-S AB with various concentra- 
tions of tropomyosin was added to the wells and incubated for 30 min 
at 37°C. Unbound proteins were washed out with PBWTween. To 
reveal TNT-S AB binding, second antibodies conjugated with 
horseradish peroxidase (10 /g/ml) were added to the wells and in- 
cubated at room temperature for 1 h. Orthophenyldiamine (2 mg/ml) 
was used as a substrate for peroxidase reaction. Optical density was 
read at 492 nm using a Titertek Multiskan automatic 
microphotometer (Flow, U.K.). 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
All reagents used were of analytical grade. The following proteins 
were purified by previously described methods: chicken gizzard 
caldesmon [7], rabbit liver caldesmon [8], rabbit skeletal troponin T 
[9] and chicken gizzard tropomyosin [lo]. Chymotrypsinolysis of 
caldesmon by cY-chymotrypsin was performed according to 
Szpacenko and Dabrowska [ll]. Protein coupling to CNBr-activated 
Sepharose-4B (Pharmacia) was performed according to the manufac- 
turer’s instructions. Polyclonal antibodies to chicken gizzard smooth 
muscle caldesmon were characterized earlier [4]. The troponin T- 
specific pool of caldesmon antibodies (TNT-S AB) was affinity- 
purified on troponin T-Sepharose 4B. By ELISA, TNT-S AB 
Figs. 1, 2A show that interaction of tropomyosin 
with immobilized caldesmon and troponin T attenuates 
the binding of TNT-S AB to these proteins. As shown 
in figs. 1, 2B, tropomyosin added together with TNT-S 
AB inhibits the binding of antibodies to caldesmon and 
troponin T in a concentration-dependent manner. 
Maximum inhibition of the TNT-S AB binding to 
caldesmon and troponin T was reached at 40-fold and 
5-fold molar excess of tropomyosin over the antibodies, 
respectively. 
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Purified M, 77 kDa caldesmon from rabbit liver was 
positively stained by troponin T-specific antibodies in 
immunoblotting (inset in fig. 1 B). 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 263 
Volume 262, number 2 F’EBSLETTERS March 1990 
1,25 
% 
t 
:: 
1.00~ 
0.75 
4 
1 
8 
[TNT-S AB], yg/ml [TNT-S AB], yg/ml 
0 4’0 8’0 
[Tropomyosin], yg/ml 
Fig. 1. The effect of tropomyosio on the binding of TNT-S AB to im- 
mobilized caldesmon. (A) Titration of immobilized caldesmon (0) 
and caldesmon preincubated with tropomyosin (e) by TNT-S AB. 
(B) Titration of immobilized caldesmon by tropomyosin in the 
presence of 2 &ml TNT-S AB. Inset shows SDS PAGE track of M, 
77 kDa caldesmon (left) and corresponding blot, stained with TNT-S 
AB (right). 
The inhibition of TNT-S AB binding to immobilized 
caldesmon or troponin T by tropomyosin may be ex- 
plained by competition of antibodies and tropomyosin 
for common binding sites on caldesmon and troponin 
T. With immobilized caldesmon, the antibody binding 
to it could not be prevented completely even at high 
concentrations of tropomyosin (fig. 1B). Presumably, 
there is a pool of high affinity binding antibodies in 
TNT-S AB preparation which cannot be displaced by 
tropomyosin at concentrations used, since the affinity 
of tropomyosin to caldesmon is weak (approx. iu, 10’ 
M-‘) [14]. 
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Fig.2. The effect of tropomyosin on the binding of TNT-S AB to im- 
mobilized troponin T. (A) Titration of immobilized troponin T (0) 
and troponin T preincubated with tropomyosin (m) by TNT-S AB. 
(B) Titration of immobilized troponin T by tropomyosin in the 
presence of 8 fig/ml TNT-S AB. 
In contrast, when caldesmon was substituted by 
troponin T, the entire inhibition of troponin T - TNT-S 
AB binding was achieved at 5-fold molar excess of 
tropomyosin over antibodies. These findings suggest 
that the affinities of TNT-S AB and tropomyosin to the 
binding sites on immobilized troponin T are com- 
parable to each other. Caldesmon may also contain 
several tropomyosin binding sites with different af- 
finities to tropomyosin and TNT-S AB. We observed 
that TNT-S AB stained only the portion of A4r 150 kDa 
caldesmon chymotryptic fragments revealed by original 
caldesmon antibodies. Among those fragments M, 38 
kDa C-terminal caldesmon fragment reacted positively 
with TNT-S AB (data not shown). These findings are 
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consistent with the mapping of tropomyosin binding 
site in the C-terminal fragment of smooth muscle 
caldesmon on the basis of the amino acid sequence 
analysis [ 151. TNT-S AB reacted with iW, 77 kDa 
caldesmon in immunoblotting (inset in fig.lB). Thus, 
M, 77 kDa caldesmon also contains amino acid se- 
quences similar to those found in smooth muscle 
caldesmon and troponin T and involved in tropomyosin 
binding. 
In conclusion, common amino acid sequences reveal- 
ed in caldesmon and skeletal troponin T were suggested 
to be involved in tropomyosin binding. The present 
work confirms the primary structure data by functional 
tests on the binding of tropomyosin to the similar sites 
on caldesmon and troponin T. 
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